Zhang, Xiaozhu
Van Treeck, Briana
Horton, Connor A. http://orcid.org/0000-0001-6018-3556
McIntyre, Jeremy J. R.
Palm, Sarah M.
Shumate, Justin L.
Collins, Kathleen http://orcid.org/0000-0003-3172-7088
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (DP1 HL156819)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM139306)
Article History
Received: 14 December 2022
Accepted: 10 January 2024
First Online: 20 February 2024
Competing interests
: X.Z., B.V.T., C.A.H., J.J.R.M., S.P. and K.C. are listed inventors on patent applications filed by University of California, Berkeley related to the 2-RNA delivery platform. X.Z., B.V.T. and K.C. have equity options in Addition Therapeutics, Inc., which licensed the UC Berkeley technology. The other authors declare no competing interests.